Harvard Apparatus Regenerative Technology Investor Relations Material
Latest events
Q3 2023
Harvard Apparatus Regenerative Technology
Q1 2025
13 May, 2025
Q4 2024
30 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harvard Apparatus Regenerative Technology Inc
Access all reports
Harvard Apparatus Regenerative Technology Inc is a U.S.-based biotechnology company developing regenerative medicine solutions. The company focuses on bioengineered implants for airway reconstruction using scaffold and cell technologies. Its research is aimed at treating life-threatening conditions such as tracheal damage and lung diseases. The company is headquartered in Holliston, Massachusetts, and its shares are listed on the OTCQB.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
HRGN
Country
🇺🇸 United States